Emergency Medicine

A-HeFT

Study

AATAC

Study

Abdominal aortic aneurysm

Disease

Abdominal distension

Finding

Abdominal vascular injury

Disease

ABYSS

Study

Accidental hypothermia

Disease

ACCOMPLISH

Study

ACCORD BP

Study

ACCORD Lipid

Study

ACE-PROTAVI

Study

ACES

Study

Acetaminophen overdose

Disease

Acetylcysteine

Drug

ACORN

Study

ACT

Study

ACTIV-3-TICO

Study

ACTIV-4A (P2Y12 inhibitor plus heparin)

Study

ACTIV-4a (SGLT2 inhibitors)

Study

ACTIV-4C

Study

ACTIV-6 (fluvoxamine)

Study

ACTIV-6 (ivermectin)

Study

ACTIV-6 (montelukast)

Study

ACTIVE A

Study

ACTIVE W

Study

ACTT-1

Study

ACTT-4

Study

Acute altitude illness

Disease

Acute appendicitis

Disease

Acute back pain

Finding

Acute cholangitis

Disease

Acute cholecystitis

Disease

Acute cholecystitis — Diagnosis and management

Pathway

Acute colonic pseudo-obstruction

Disease

Acute compartment syndrome

Disease

Acute diverticulitis

Disease

Acute diverticulitis — Counseling and follow-up

Pathway

Acute diverticulitis — Diagnosis and management

Pathway

Acute fatty liver of pregnancy

Disease

Acute interstitial nephritis

Disease

Acute ischemic stroke

Disease

Acute kidney injury

Disease

Acute limb ischemia

Disease

Acute liver failure

Disease

Acute mesenteric ischemia

Disease

Acute pain

Disease

Acute pancreatitis

Disease

Acute pericarditis

Disease

Acute pyelonephritis

Disease

Acute urticaria

Disease

ADAPT-PO

Study

ADAPT-TAVR

Study

ADH-Wizard

Study

ADMINISTER

Study

Adnexal torsion

Disease

ADVOR

Study

AECOPD

Study

AF-CHF

Study

AFFINITY

Study

AFFIRM

Study

AGENT IDE

Study

AHA STEROID

Study

AIRFLO

Study

AIRTRIP

Study

AIRWAY-2

Study

AKIKI

Study

Albumin for CSA-AKI

Study

Albumin for SBP

Study

Albuterol

Drug

Alcohol withdrawal syndrome

Disease

ALLEVIATE

Study

ALLHAT (angiotensin-converting enzyme inhibitor)

Study

ALLHAT (calcium channel blocker)

Study

ALLIUM

Study

Altshock-2

Study

AMETIS

Study

Amiodarone

Drug

AMPLIFY (apixaban)

Study

AMPLIFY-EXT (apixaban 2.5 mg)

Study

AMPLIFY-EXT (apixaban 5 mg)

Study

Amylase, increased

Finding

Anaphylaxis

Disease

Andexanet alfa

Drug

ANGEL-ASPECT

Study

Angioedema

Finding

Animal bites

Disease

Anisocoria

Finding

Ankle fracture

Disease

Ankle sprain

Disease

ANNEXA-I

Study

Anorectal abscess

Disease

Anorectal varices

Disease

Anterior cruciate ligament injury

Disease

ANTHARTIC

Study

Antimicrobial prophylaxis in pancreatoduodenectomy

Study

Aortic intramural hematoma

Disease

Aortic stenosis

Disease

APEX

Study

APPIC

Study

ARAIS

Study

ARAMIS

Study

ARBs CORONA II

Study

ARCADIA (original research)

Study

ARCADIA (post-hoc analysis)

Study

ARCADIA-MRI

Study

ARIES-HM3 (original research)

Study

ARIES-HM3 (secondary analysis)

Study

ARISTOTLE

Study

ARREST

Study

ARRIVE (aspirin)

Study

ARTESIA

Study

ASPIRE

Study

Aspirin overdose

Disease

ASPRE

Study

ASPREE

Study

ASPREE (secondary analysis)

Study

ASTRAL

Study

ATACH II

Study

ATAMIS

Study

ATLAS ACS 2-TIMI 51 (rivaroxaban 10 mg)

Study

ATLAS ACS 2-TIMI 51 (rivaroxaban 5 mg)

Study

ATN

Study

Atrial fibrillation

Disease

ATTENTION-IA

Study

ATTKPATRASCOVID19

Study

ATTR-ACT

Study

ATTRACT

Study

ATTRibute-CM

Study

AUGUSTUS (anticoagulation regimen)

Study

AUGUSTUS (antiplatelet regimen)

Study

AURORA (rosuvastatin)

Study

AVATAR

Study

AVB-TIPS

Study

AVERROES

Study

AVERT

Study

AVERT Shock

Study

AVOID

Study

AWARE

Study

AZALEA-TIMI 71 (high-dose abelacimab)

Study

AZALEA-TIMI 71 (low-dose abelacimab)

Study